North American Neuromodulation Market to Grow at a CAGR of 10.7% to reach US$ 6,612.00 million from 2020 to 2027

North American Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology [External (Non-Invasive) Neuromodulation and Internal Neuromodulation], Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine), and End User (Hospitals, Clinics, and Home Healthcare) and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016293 | No. of Pages: 108 | Category: Medical Device | Status: Published
Covid

The Neuromodulation market in North America is expected to grow from US$ 3,029.72 million in 2019to ;[ by 2027. This represents a CAGR of 10.6% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to increasing incidence of neurological disorders, growing developments in neuromodulation technology are projected to drive the North America neuromodulation market during the forecast period.

                                

The US has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in North America during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation


US Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)

US Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :


 

NORTH AMERICA NEUROMODULATION  – MARKET SEGMENTATION

By Technology

·      External (Non-Invasive) Neuromodulation

o     Respiratory Electrical Stimulation

o     Transcutaneous Electrical Nerve Stimulation

o     Transcranial Magnetic Stimulation

·      Internal Neuromodulation

o     Deep Brain Stimulation

o     Sacral Nerve Stimulation

o     Gastric Electrical Stimulation

o     Spinal Cord Stimulation

o     Vagus Nerve Stimulation

 

By Application

·      Chronic Pain Management

·      Failed Back Syndrome

·      Epilepsy

·      Tremor

·      Incontinence

·      Depression

·      Dystonia

·      Gastroparesis

·      Parkinson’s Disease

·      Obsessive-Compulsive Disorder

·      Migraine

By End User

·      Hospitals

·      Clinics

·      Home Healthcare

By Country

·      US

·      Canada

·      Mexico

 

Company Profiles

Abbott

Boston Scientific Corporation

Medtronic

NeuroPace, Inc.

NeuroSigma, Inc.

NEVRO CORP.

Synapse Biomedical Inc.

Soterix Medical Inc

Integer Holdings Corporation

Magstim

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Neuromodulation Market – By Technology

1.3.2        Neuromodulation Market – By Application

1.3.3        Neuromodulation Market – By End User

1.3.4        North America Neuromodulation Market – By Country

2.             Neuromodulation Market – Key Takeaways

2.1       Coverage

2.2       Secondary Research

2.3       Primary Research

3.             North America Neuromodulation– Market Landscape

3.1       Overview

3.2       PEST Analysis

3.2.1        Expert Opinions

4.             Neuromodulation Market – Key Market Dynamics

4.1       Market Drivers

4.1.1        Increasing Incidence of Neurological Disorders

4.1.2        Growing Developments in Neuromodulation Technology

4.2       Market Restraints

4.2.1        High Cost of Neuromodulation Devices

4.3       Market Opportunities

4.3.1        Rising Demand for Neurostimulation Devices to Treat Chronic Pain

4.4       Future Trends

4.4.1        Technological Advancements

4.5       Impact Analysis

5.             Neuromodulation Market Analysis – By Technology

5.1       Overview

5.2       Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

5.3       External Neuromodulation

5.3.1        Overview

5.3.2        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.3        Respiratory Electrical Stimulation (RES)

5.3.3.1      Overview

5.3.3.2      Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.4        Transcutaneous Electrical Nerve Stimulation (TENS)

5.3.4.1      Overview

5.3.4.2      Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.5        Transcranial Magnetic Stimulation (TMS)

5.3.5.1      Overview

5.3.5.2      Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4       Internal Neuromodulation

5.4.1        Overview

5.4.2        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.3        Deep Brain Stimulation (DBS)

5.4.3.1      Overview

5.4.3.2      Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.4        Sacral Nerve Stimulation (DBS)

5.4.4.1      Overview

5.4.4.2      Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.5        Gastric Electric Stimulation (GES)

5.4.5.1      Overview

5.4.5.2      Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.6        Spinal Cord Stimulation (SCS)

5.4.6.1      Overview

5.4.6.2      Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.7        Vagus Nerve Stimulation (VNS)

5.4.7.1      Overview

5.4.7.2      Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.             Neuromodulation Market Analysis – By Application

6.1       Overview

6.2       Neuromodulation Market Share, by Application, 2019 and 2027 (%)

6.3       Chronic Pain Management

6.3.1        Overview

6.3.2        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4       Failed Back Syndrome

6.4.1        Overview

6.4.2        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.5       Epilepsy

6.5.1        Overview

6.5.2        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.6       Tremor

6.6.1        Overview

6.6.2        Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.7       Incontinence

6.7.1        Overview

6.7.2        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.8       Depression

6.8.1        Overview

6.8.2        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.9       Dystonia

6.9.1        Overview

6.9.2        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.10    Gastroparesis

6.10.1     Overview

6.10.2     Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.11    Parkinson’s Disease

6.11.1     Overview

6.11.2     Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.12    Obsessive-Compulsive Disorder (OCD)

6.12.1     Overview

6.12.2     Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.13    Migraine

6.13.1     Overview

6.13.2     Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.             Neuromodulation Market Analysis – By End User

7.1       Overview

7.2       Neuromodulation Market Share, by End User, 2019 and 2027, (%)

7.3       Hospitals

7.3.1        Overview

7.3.2        Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Clinics

7.4.1        Overview

7.4.2        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Home Healthcare

7.5.1        Overview

7.5.2        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.             Neuromodulation Market Analysis and Forecasts To 2027 – Regional Analysis

8.1       North America: Neuromodulation Market

8.1.1        Overview

8.1.2        North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

8.1.3        North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.3.1      North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.3.2      North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.4        North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.5        North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.6        North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

8.1.7        US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1      US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2      US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.7.2.1       US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.7.2.2       US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.7.3      US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.7.4      US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.8        Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1      Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2      Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.8.2.1       Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.8.2.2       Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.8.3      Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.8.4      Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.9        Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1      Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2      Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.9.2.1       Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.9.2.2       Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.9.3      Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.9.4      Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Impact of COVID-19 Pandemic on North America Neuromodulation Market

8.2       North America: Impact Assessment of COVID-19 Pandemic

9.             Company Profiles

9.1       Abbott

9.1.1        Key Facts

9.1.2        Business Description

9.1.3        Products and Services

9.1.4        Financial Overview

9.1.5        SWOT Analysis

9.1.6        Key Developments

9.2       Boston Scientific Corporation

9.2.1        Key Facts

9.2.2        Business Description

9.2.3        Products and Services

9.2.4        Financial Overview

9.2.5        SWOT Analysis

9.2.6        Key Developments

9.3       Medtronic

9.3.1        Key Facts

9.3.2        Business Description

9.3.3        Products and Services

9.3.4        Financial Overview

9.3.5        SWOT Analysis

9.3.6        Key Developments

9.4       NeuroPace, Inc.

9.4.1        Key Facts

9.4.2        Business Description

9.4.3        Products and Services

9.4.4        Financial Overview

9.4.5        SWOT Analysis

9.4.6        Key Developments

9.5       NeuroSigma, Inc.

9.5.1        Key Facts

9.5.2        Business Description

9.5.3        Products and Services

9.5.4        Financial Overview

9.5.5        SWOT Analysis

9.5.6        Key Developments

9.6       Nevro Corp.

9.6.1        Key Facts

9.6.2        Business Description

9.6.3        Products and Services

9.6.4        Financial Overview

9.6.5        SWOT Analysis

9.6.6        Key Developments

9.7       Synapse Biomedical Inc.

9.7.1        Key Facts

9.7.2        Business Description

9.7.3        Products and Services

9.7.4        Financial Overview

9.7.5        SWOT Analysis

9.7.6        Key Developments

9.8       Soterix Medical Inc

9.8.1        Key Facts

9.8.2        Business Description

9.8.3        Products and Services

9.8.4        Financial Overview

9.8.5        SWOT Analysis

9.8.6        Key Developments

9.9       Integer Holdings Corporation

9.9.1        Key Facts

9.9.2        Business Description

9.9.3        Products and Services

9.9.4        Financial Overview

9.9.5        SWOT Analysis

9.9.6        Key Developments

9.10    Magstim

9.10.1     Key Facts

9.10.2     Business Description

9.10.3     Products and Services

9.10.4     Financial Overview

9.10.5     SWOT Analysis

9.10.6     Key Developments

10.          Appendix

10.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 13.          Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 18.          Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Glossary of Terms, Neuromodulation Market

 

LIST OF FIGURES

Figure 1.           Neuromodulation Market Segmentation

Figure 2.           Neuromodulation Market – By Geography

Figure 3.           North America Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America Neuromodulation Market- Leading Country Markets (US$ Million)

Figure 7.           Research Methodology

Figure 8.           North America PEST Analysis

Figure 9.           Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 10.        Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 11.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 15.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 22.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 34.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        North America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 38.        North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 39.        North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 40.        US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Impact of COVID-19 Pandemic in North American Country Markets

 

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  1. Magstim
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the North Americanneuromodulationmarket

 

  • Highlights key business priorities to assist companies in order to realign their business strategies

 

  • Highlightskey findings and recommendations of crucial progressive industry trends in the North Americanneuromodulationmarket, thereby allowing players across the value chain to develop effective long-term strategies

 

  • Develops/modifiesbusiness expansion plans by using substantial growth offering developed and emerging markets

 

  • Scrutinizes in-depth North American market trends and outlook coupled with the factors driving the market, as well as those hindering it

 

  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TIPRE00016293
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing